FAQs BPC-157 (Body Protection Compound-157) is a synthetic peptide widely used in research for its potential to accelerate healing of musculoskeletal injuries, including tendons, ligaments, muscles, and bones
After 12 treatment sessions, patients were assessed for pain intensity, knee flexion range of motion, a timed up-and-go test, a 6-min walk test, and knee functionality compared to pre-treatment baseline measurements
One of the most unique features of BPC-157 is that its biological effects often outlast its physical presence in the body
Over the extended FY2007-2012 period, during which CPP and then CRP were implemented, more than 100 AF STTPs and SMTPs used about $92 million in CRP/CPP funding but also attracted almost $340 million in additional funding, including $152 million from AF acquisitions offices and a further $54 million from industry sources (see Figure 4-3)